메뉴 건너뛰기




Volumn 12, Issue 4, 2011, Pages 257-258

Safety and pharmacokinetics of etravirine in pregnant HIV-1-infected women

Author keywords

[No Author keywords available]

Indexed keywords

DARUNAVIR PLUS RITONAVIR; ENFUVIRTIDE; ETRAVIRINE;

EID: 79952288406     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2010.00874.x     Document Type: Letter
Times cited : (22)

References (5)
  • 1
    • 79952290603 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of the non-nucleoside reverse transcriptase inhibitor etravirine in treatment-experienced HIV-1-infected patients. Clin Pharmacol Ther. In press.
    • Kakuda TN, Wade JR, Snoeck E et al. Pharmacokinetics and pharmacodynamics of the non-nucleoside reverse transcriptase inhibitor etravirine in treatment-experienced HIV-1-infected patients. Clin Pharmacol Ther. In press.
    • Kakuda, T.1    Wade, J.2    Snoeck, E.3
  • 2
    • 79952292977 scopus 로고    scopus 로고
    • Etravirine has no effect on fetal development in rats and rabbits. 17th International AIDS Conference. Mexico City, Mexico, August 2008 [Abstract TUPE0013].
    • Raoof A, Lachau-Durand S, Verbeeck J, Bailey G, Martens M. Etravirine has no effect on fetal development in rats and rabbits. 17th International AIDS Conference. Mexico City, Mexico, August 2008 [Abstract TUPE0013].
    • Raoof, A.1    Lachau-Durand, S.2    Verbeeck, J.3    Bailey, G.4    Martens, M.5
  • 3
    • 84855618531 scopus 로고    scopus 로고
    • Pharmacokinetics of etravirine are not affected by sex, age, race, treatment duration or use of enfuvirtide in HIV-1-infected subjects. 17th International AIDS Conference. Mexico City, Mexico, August 2008 [Abstract TUPE0082].
    • Kakuda TN, Schöller-Gyüre M, Peeters M et al. Pharmacokinetics of etravirine are not affected by sex, age, race, treatment duration or use of enfuvirtide in HIV-1-infected subjects. 17th International AIDS Conference. Mexico City, Mexico, August 2008 [Abstract TUPE0082].
    • Kakuda, T.1    Schöller-Gyüre, M.2    Peeters, M.3
  • 4
    • 59849126824 scopus 로고    scopus 로고
    • Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance
    • Furco A, Gosrani B, Nicholas S et al. Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance. AIDS 2009; 23: 434-435.
    • (2009) AIDS , vol.23 , pp. 434-435
    • Furco, A.1    Gosrani, B.2    Nicholas, S.3
  • 5
    • 79952284982 scopus 로고    scopus 로고
    • Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2009. Wilmington, NC: Registry Coordinating Center, 2009. Available at (accessed 19 May 2010).
    • Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2009. Wilmington, NC: Registry Coordinating Center, 2009. Available at (accessed 19 May 2010).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.